Wednesday 29 March 2017

Fight against patent for hepatitis C drug that can cost €55,000

Sofosbuvir can cost up to €55,000 for a course of treatment. Charities hope revoking the patent would allow far cheaper generics to cure hepatitis C in Europe via New Scientist - Health Read More Here.. Lake forest health and fitness http://ift.tt/2oiA9Vn

No comments:

Post a Comment